News

15 October 2009

Opening of the Italian market

Spineart has announced the opening of the Italian market by signing with the MBA group. MBA is a medical device marketing and distribution organization and specializes in the sale of products used for treatment of the spine. MBA is the largest private independent distributor of orthopedic devices in Europe, generating more than $100 million in total sales in 2008.

14 October 2009

2'300 Cervical Disc Prostheses BAGUERA®C implanted worldwide

Spineart is proud to announce that their cervical disc prosthesis BAGUERA®C has successfully been implanted more than 2.300 times worldwide within the last 2 1/2 years with very satisfying results. BAGUERA®C is the world’s first MRI compatible, pre-assembled, and shock absorbing cervical artificial disc containing a guided mobile PE inlay.

14 October 2009

510k approval for TRYPTIK® CA Cervical Interbody Cage

Spineart has announced the 510k approval for their TRYPTIK® CA cervical interbody cage. The cage follows Spineart's unique load sharing concept, which is designed to accelerate and improve the fusion process. To date the TRYPTIK®CA cervical cage has been implanted over 5.000 times worldwide.

14 October 2009

510k approval for JULIET® Lumbar Interbody Cages

Spineart has announced the 510k approval for theirJULIET® lumbar interbody fusion cage range. The range includes ALIF, PLIF and TLIF cages that all follow Spineart's unique load sharing concept, which is designed to accelerate and improve the fusion process. To date the JULIET® cages have been implanted over 9.000 times worldwide.

14 October 2009

510k approval for ROMEO® Posterior Fixation System

Spineart has announced the 510k approval for their ROMEO® posterior fixation system. The screws are designed to center themselves while being inserted into the pedicle to facilitate and increase the safety of the surgical procedure. To date the ROMEO® screws have been implanted over 20.000 times worldwide.

14 October 2009

Spineart opens its US offices

Spineart, leader of a new spinal generation, is proud to announce the opening of its US subsidiary the 1st of September 2009. The office is located in Manhattan, New York City. This furthermore underlines the ambitious execution of Spineart’s corporate strategy and its 2nd geographic development phase after the establishment in Europe. The new US headquarter includes the sales, scientific and R&D departments in order to meet the US market demands.